Platelet-rich plasma and bone graft materials: A review and a standardized research protocol

Implant Dentistry

Volumn 13, Issue 4, 2004, Pages 301-309

  Grageda, Edgar ^a,b,c  

^a LOMA LINDA UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c NONE   (United States)

Author keywords

Allograft; Autograft; Growth factors; Xenograft

Indexed keywords

GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR; SOMATOMEDIN; TRANSFORMING GROWTH FACTOR BETA;

ALLOGRAFT; BONE GRAFT; HUMAN; REVIEW; THROMBOCYTE RICH PLASMA; XENOGRAFT;

ANIMALS; BLOOD PLATELETS; BONE REGENERATION; BONE SUBSTITUTES; BONE TRANSPLANTATION; DENTAL RESEARCH; GELS; GROWTH SUBSTANCES; GUIDELINES; HUMANS; RESEARCH DESIGN;

EID: 11444252644     PISSN: 10566163     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.id.0000148555.91063.06     Document Type: Review

References (98)

1. De Boer HN. History of bone grafts. Clin Orthop. 1988;226:292-298.
2. Misch C. Bone grafting materials in implant dentistry. Implant Dent. 1993;2: 158-167.
3. Boyne PJ. Maxillofacial surgery. In: Habal M, ed. Bone Grate and Bone Substitutes. Philadelphia: WB Saunders; 1992: 291-298.
4. Bourchardt H. The biology of bone graft repair. Clin Orthop. 1983;174:28-42.
5. Goldberg VM, Stevenson S. Natural history of autografts and allografts. Clin Orthop. 1989;225:7-16.
6. Boyne PJ, Peetz M. Osseous Reconstruction of the Maxilla and the Mandible: Surgical Techniques Using Titanium Mesh and Bone Mineral. Hong Kong: Quintessence Co; 1997:3-13.
7. Buck BE, Malinin TI. Human bone and tissue allografts preparation and safety. Clin Orthop. 1994;303:8-17.
8. Russo R, Scarborough N. Inactivation of viruses in demineralized bone matrix DBM. FDA workshop on tissue for transplantation and reproductive tissue. June 20-21, 1995.
9. Sampath YK, Reddi AH. Distribution of bone inductive proteins in mineralized and demineralized extracellular matrix. Bioque Biophy Res Commun. 1984; 119:949-954.
10. Urist MR, Strates B. Bone formation in implants of partially of and wholly demineralized bone matrix. Clin Orthop. 1970;71:271-278.
11. Meffert RA. Current usage of bone fill in implant dentistry. Dental Implant (update). 1998;9:9-12.
12. Urist MR, Dowell TA. Inductive substrates for bone formation. Clin Orthop. 1968;59:59-96.
13. Urist MR, Dowell TA. Inductive substratum for osteogenesis in pellets of particulate bone matrix. Clin Orthop. 1968; 61:61-77.
14. Reddi AH, Higgins CH. Biochemical sequences in the transformation of normal fibroblasts in adolescent rat. Proc Natl Acad Sci USA. 1972;69:6:1601-1605.
15. Fuccini SE, Quintero G. Small versus large particles of demineralized freeze dried bone allografts in human intrabony periodontal defects. J Periodontol. 1993; 64:844-847.
16. Moore TM, Artal M. Influence of postmortem time and temperature on osteoinductive activity of demineralized microperforated ethylene oxide-sterilized syngeneic bone implant in the rat. Clin Orthop. 1990;259:239-234.
17. Urist MR, Mikulski A, Boyd SD. A chemosterilized antigen-extracted autodigested alloimplants for bone banks. Arch Surg. 1975;110:416-418.
18. Schwartz Z et al. Ability of commercial demineralized freeze-dried bone allograft to induce new bone formation is dependent on donor age but not gender. J Periodontol. 1998;69:470-478.
19. Caplanis N. Guided bone regeneration of supra-alveolar peri-implant defects in dogs. Masters thesis. 1996.
20. Saaduon A. Commentary and analysis. Implant Dent. 1999;8:4:347-354.
21. Hollinger JO, Breckle J, Gruskin E, et al. Role of bone substitutes. Clin Orthop. 1996;324:55-65.
22. Bucholz RW. Non allografts osteoconductive bone graft substitutes. Clin Orthop. 2002;395:44-52.
23. Laurencin CT, Lu HH. Polymerceramic composites for bone-tissue engineering. Bone Engineering. Toronto: EM Squared; 2000:462-472.
24. Harvey WK, Pincock JL, Matukas VJ, et al. Evaluation of subcutaneous implanted hydroxyapatite-avitane mixture in rabbits. J Oral Maxillofac Surg. 1985;43: 227-280.
25. Pettis GY, Kaban LB, Glowacki J. Tissue response to complete ceramic hydroxyapatite/demineralized bone implants. J Oral Maxillofac Surg. 1990;48: 1068-1074.
26. Dong J, Uemura T, Shirasaki Y, et al. Promotion of bone formation using highly pure porous B-TCP combined with bone marrow-derived osteprogenitor cells. Biomaterials. 2002;23:4493-4502.
27. Jensen SS, Pinholt EM, Horting-Hansen E, et al. Tissue reaction and material characteristics of four bone substitutes. Int J Oral Maxillofac Implants. 1996;11:55-66.
28. Spector M. Anorganic bovine bone and ceramic analogs of bone mineral as implants to facilitate bone regeneration. Clin Plast Surg. 1994;21:437-444.
29. Cohen RE, Mullarky RH, Noble B, et al. Phenotypic characterization of mononuclear cells following anorganic bovine bone implantation in rats. J Periodontol. 1994;65:1008-1015.
30. Peetz M. Characterization of xenogeneic bone material [Appendix]. In: Boyne PJ, ed. Osseous Reconstruction of the Maxilla and the Mandible: Surgical Techniques Using Titanium Mesh and Bone Mineral. Chicago: Quintessence Books; 1997:87-100.
31. Marx R, Carlson ER, Eichstaedt RM, et al. Platelet Rich Plasma growth factors enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endo. 1998;85:638-646.
32. Marx R. Platelet concentrate: a strategy for accelerating and improving bone regeneration. In: Davies JB, ed. Bone Engineering. Toronto: Em Squared Inc; 2000:447-453.
33. Marx R. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001;10:225-228.
34. Ksander GA, Sawamura SJ, Ogawa Y, et al. The effect of platelet releasate on wound healing in animal models. J Am Acad Dermatol. 1990;22:781-791.
35. Canalis E. The hormonal and local regulation of bone formation. Endocr Rev. 1983;4:62-77.
36. Cooper GM. The Cell: A Molecular Approach, 2nd ed. Washington, DC: ASM Press; 2000:525-570.
37. Canalis E, McCarthy T, Centrella M. Growth factors and the regulation of bone remodeling. J Clin Invest. 1988;81:277-281.
38. Landsberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Maxillofac Surg. 2000;58:297-300.
39. Betsholtz C, Johnsson A, Heldin CH, et al. cDNA sequence and chromosomal localization of the human platelet-derived growth factor A-chain and it expression in tumor cell lines. Nature. 1986;320:695-699.
40. Centrella M, McCarthy TL, Ladd C. Expression of PDGF and regulation of PDGF binding are isoforms specific in osteoblast enriched cultures from fetal rat bone. J Bone Miner Res. 1990;5(suppl):86.
41. Kasperk C, Werdegal JE, Mohan S, et al. Interaction of growth factors present in bone matrix and bone cells: effects on DNA synthesis and alkaline phosphatase. Growth Factors. 1990;3:147-154.
42. Linkhart TA, Jennings JC, Mohan S. Characterization of mitogenic activities extracted from bovine bone matrix. Bone. 1989;4(suppl):214.
43. Heldin CH, Westermarick B. PDGF-like growth factors in autocrine stimulation of growth. J Cell Physiol. 1987:5:31-34.
44. Rydsier S, Shaikh S, Canalis E. PDGF AA and BB enhance the synthesis of PDGF AA in bone cells in culture. Endocrinology. 1994;134:2541-2546.
45. Holk JM, Canalis E. PDGF enhances bone cell replication but not differentiated function of osteoblast. Endocrinology. 1994;134:1423-1428.
46. Howes R, Bowness JM, Grotendorst GR, et al. PDGF enhances demineralized bone matrix-induced cartilage and bone formation. Calcif Tissue Int. 1988;42:34-38.
47. Nash TJ, Howlett CR, Martin C, et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone. 1994;15:203-208.
48. Vikjaer D, Blom S, Horting-Hansen E, et al. Effect of PDGF on bone formation in calvarial defects. An experimental study in rabbits. Eur J Oral Sci. 1997;105:59-66.
49. Andrew JG, Hoyland J, Andrew SM, et al. PDGF expression in normal healing human fractures. Bone. 1995;16:455-460.
50. Assoian RK, Komoriya A, Meyers CA, et al. Transforming growth factor-beta in human platelets. Identification of a major storage site, purification and characterization. J Biol Chem. 1983;258:7155-7160.
51. Roberts AB. Physiological actions and clinical applications of transforming growth factor-B (TGF-B). Growth Factors. 1993;8:1-9.
52. Centrella M, McCarthy T, Canalis E. Transforming growth factors beta is a bifunctional regulator of replication and collagen synthesis in osteoblast enriched cell cultures from fetal rat bone. J Biol Chem. 1987;262:2869-2874.
53. Sampath TK, Muthukumaran N, Reddi AH. Isolation of osteogenin, an extracellular matrix-associated, bone inductive protein, by heparin affinity chromatography. Proc Natl Acad Sci U S A. 1987;84:7109-7113.
54. Kiebblewhite DJ, Bruce AG, Strong DM, et al. TGF-B accelerates osteoinduction in a craniofacial onlay model. Growth Factors. 1993;9:185-193.
55. Beck LS, Ammann AJ, Aufdemorte TB, et al. In vivo induction of bone by rhTGF-BI. J Bone Miner Res. 1991;6:961-968.
56. Beck LS, Amento EP, Xu Y, et al. TGF-BI induces bone closure of skull defects. Temporal dynamics of bone formation in defects exposed to rhTGF-BI. J Bone Miner Res. 1993;8:753-761.
57. Ripamonti U, Bosch C, Van den Heever B, et al. Limited chondroosteogenesis by rhTGF-BI in calvarial defects of adult baboons. J Bone Miner Res. 1996;11:938-945.
58. Lind M, Schumacker B, Soballe K, et al. TGF-B enhances healing in rabbit tibiae. Acta Orthop Scand. 1993;64:553-556.
59. Canalis E, et al. Effects on IGF-I on DNA and protein synthesis in cultured rat. J Clin Invest. 1980;66:709-719.
60. Canalis E, et al. IGF and osteoporosis bone. J Clin Invest. 1997;21:215-216.
61. Mohan S, Baylink DJ. Bone growth factors. Clin Orthop. 1991;263:30-48.
62. Mott DA, Mailhot J, Cuenin MF, et al. Enhancement of osteoblast proliferation in vitro by selective enrichment of demineralized freeze dried bone allograft with specific growth factors. J Oral Implantol. 2002; 28:57-66.
63. Jiang D, Dziak R, Lynch SE, et al. Modification of an osteoconductive anorganic bovine bone mineral matrix with growth factors. J Periodontol. 1999;70:834-839.
64. Wironen JF, Jaw RY, Fox WC. Platelet-rich plasma is not osteoinductive in a nude rat assay. Presented at the International Conference of Bone Substitutes; Davos, Switzerland; October 8-10, 2000.
65. Furst G, Donath K, Tangl ST, et al. Sinus augmentation in minipigs using autogenous platelet-rich plasma (PRP) and xenogeneic hydroxyapatite. Clin Oral Impl Res. 2001;12:393-421, Abstract 37.
66. Neukam FW. Application of PRP in implantology. Presented at the Mediterranean Dental Implant Congress; Corfu, Greece; June 13-19, 2002.
67. Terheyden H. Experimentelle Sinus-bodenaugmentation: Vergleich verschiedener Tragermaterialien mit undohne rhOP-1 und vergleich der biologischen factoren PRP und rhOP-1. Presented at the sinus-lift Konferenz Hamburg, Germany; September 9, 2000.
68. Froum SJ, Wallace SS, Tarnow DP, et al. Effect of platelet-rich plasma on bone growth and osseointegration in human maxillary sinus grafts: three bilateral case reports. Int J Periodontics Rest Dent. 2002;22:45-53.
69. Shanaman R, Filstein MR, Danesh-Mayer MJ. Localized ridge augmentation using GBR and platelet-rich plasma: case report. Int J Periodontics Res Dent. 2001;21:345-355.
70. Okasaki Y, Watanabe K, Hatanaka T, et al. Sinus floor augmentation using a combination of B-tricalcium phosphate and platelet-rich plasma. Clin Oral Ompl Res. 2001;12:393-421, Abstract 76.
71. Su-Gwan K, Chae-Heon CH, Young-Kyun K, et al. Use of particulate dentin-plaster of Paris combination with/ without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants. 2002;17:86-94.
72. Agballo TL, Moy P, Freymiller EG. Investigation of platelet-rich plasma in rabbit cranial defect: a pilot study. J Oral Maxillofac Surg. 2002;60:1176-1181.
73. Galliani MG, Arrascue VM. Histological study to compare bone healing between experimental mandibular bone defects filled with and without platelet rich plasma, and experimental study in rabbits. J Dent Res. 2000;81 (Special Issue A): Abstract#2263, p A-288.
74. Jakse N, Lorenzini M, Eskici A, et al. PRP's influence on bone regeneration. An experimental study in sheep. European Association for Osseointegration. Oral Presentation; Brussels, Belgium; September 12-14, 2002.
75. Zuffetti F, Testori T, Fontanella W, et al. European Association for Osseointegration. Oral Presentation; Brussels, Belgium; September 12-14, 2002.
76. Wong WY, Ho KH, Harris M. Quantitative analysis of transforming growth factor-beta un human platelet concentrate and serum. J Dent Res. 2002;81(Special Issue A):Abstract 1614, p A-215.
77. Weibrich G, Kleis W, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants. 2002;17:184-190.
78. Lynch SE, Ruiz de Castilla G, Williams RC, et al. The effect of short-term application of a combination of platelet-derived and insulin-like growth factors on periodontal wound healing. J Periodontol. 1991;62:458-467.
79. Pierce GF, Mustoem TA, Senior RM, et al. In vivo incisional wound healing augmented by platelet-derived growth factor and recombinant c-sis gene homodimeric proteins. J Exp Med. 1988;167:974-987.
80. Rose C, Langman M, Davis B, et al. A cell culture method to evaluate PRP-based bone regenerative therapies. Poster Presentation; Society for Biomaterials 29th Annual Meeting Transactions; Reno, Nevada; April 31-May 2, 2003.
81. Enneking WF, Morris JL Human autologous cortical bone transplant. Clin Orthop. 1972;87:28-35.
82. Schmitz JP, Hollinger JO. The critical size defect as an experimental model for cranio-mandibular nonunions. Clin Orthop. 1986;205:299-308.
83. Kramer IRH, Kelly C, Wright HC. A histological and radiological comparison of the healing of defects of the rabbit calvarium with and without implanted heterogenous anorganic bone. Arch Oral Biol. 1968;13:1095-1106.
84. Kramer IRH, Kelly HC, Wright HC. The response of the rabbit to implants of processed calf bone (Boplant). Arch Oral Biol. 1968;13:1263-1273.
85. Reid CA, McCarthy JG, Kolber AB. A study of regeneration in parietal bone defects in rabbits. Plast Reconstr Surg. 1981;67:5:591-587.
86. Aaboe M, Pinholt EM, Horting-Hansen E. Unbiased stereological method used for the quantitative evaluation of guided bone regeneration. Clin Oral Implant Res. 1998;9:163-169.
87. Hammerle CHF, Schmid J, Lang NP, et al. Temporal dynamics of healing in rabbit cranial defect using guided bone regeneration. J Oral Maxillofac Surg. 1995;53:167-174.
88. Winn SR, Schmitt JM, Buck D, et al. Tissue engineered bone biomimetic to regenerate calvaria CSD in athymic rats. J Biomed Mater Res. 1999;45:414-421.
89. Frame JW. A convenient animal model for testing bone substitute materials. J Oral Surg. 1980;38:176-180.
90. Frame JW. A composite of porous calcium sulfate dihydrate and cyanoacrylate as a substitute for autogenous bone. J Oral Surg. 1980;38:251-260.
91. Prolo DJ, Peter W, Pedrotti MA, et al. Superior osteogenesis is transplanted allogenic canine skull following chemical sterilization. Clin Orthop. 1982;168:230-242.
92. Hollinger JO, Kleinsmith JC. The critical size defect as an experimental model to test bone repair materials. J Craniofac Surg. 1990;1:60-68.
93. Ho KCK, Nicklin S, Giaoutsos MP, et al. Critical size cranial defect in sheep: what is the size required? Poster Presentation; Society for Biomaterials 29th Annual Meeting Transactions; Reno, Nevada; April 31-May 2, 2003.
94. Marx RE, Kevy SV, Jacobson MS. Platelet concentrate preparation in the office setting: a comparison of manual and automated devices. Available at: ww-w.Harvest.com.
95. Weibrich G, Kleis WKF, Bush R, et al. The Harvest Smart PreP system versus the Friadent-Shutze platelet-rich plasma kit. Clin Oral Impl Res. 2003;14:233-239.
96. Weibrich G, Kleis WKG, Hafner G, et al. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implant Res. 2003;14:357-362.
97. Anitua E. Plasma in growth factors: preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Imp. 1999;14:529:535.
98. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. J Periodontol. 2000;71:1654-1661.